Form 4: Kellanova Merger Completes, W.K. Kellogg Trust Sells Shares

Sentiment:

Statement of Changes in Beneficial Ownership (Form 4)


The W.K. Kellogg Foundation Trust disposed of 45,097,438 shares of Kellanova common stock at $83.50 per share following the completion of a merger where Kellanova became a wholly-owned subsidiary.

Summary

  • The W.K. Kellogg Foundation Trust, a 10% owner and director of Kellanova, reported the disposal of 45,097,438 shares of Kellanova common stock.
  • The transaction occurred on December 11, 2025, at a price of $83.50 per share.
  • This disposal was a direct result of a merger completed on December 11, 2025, pursuant to an Agreement and Plan of Merger dated August 13, 2024.
  • In the merger, Merger Sub 10VB8, LLC, a wholly-owned subsidiary of Acquiror 10VB8, LLC, merged with and into Kellanova, with Kellanova surviving as a wholly-owned subsidiary of Acquiror 10VB8, LLC.
  • At the effective time of the merger, each outstanding share of Kellanova common stock was cancelled and converted into the right to receive $83.50 in cash, without interest.
  • Following the transaction, the W.K. Kellogg Foundation Trust beneficially owns 0 shares of Kellanova common stock.
  • The W.K. Kellogg Foundation is the sole beneficiary of the Trust.

Sentiment

Score: 7

Explanation: The filing reports the successful completion of a merger, resulting in a cash payout to shareholders at a specified price. This is a definitive and positive outcome for the selling shareholders, even though it marks the end of public ownership for Kellanova.

Positives

  • The W.K. Kellogg Foundation Trust received a significant cash payment of approximately $3.76 billion for its shares, providing liquidity.
  • The merger provided a clear and definitive cash exit for all public shareholders of Kellanova at a fixed price of $83.50 per share.

Negatives

  • The W.K. Kellogg Foundation Trust no longer holds any beneficial ownership in Kellanova.
  • Kellanova common stock has been cancelled, meaning public shareholders no longer hold equity in the company.

Future Outlook

NA

Industry Context

This filing reflects the finalization of a significant corporate acquisition within the consumer goods or food industry, where Kellanova, a publicly traded entity, has transitioned into a privately held subsidiary. Such transactions often indicate consolidation trends or strategic realignments within the sector, potentially driven by market conditions, competitive pressures, or a desire for operational efficiencies away from public scrutiny.

Stakeholder Impact

  • Shareholders of Kellanova received $83.50 per share in cash, converting their equity into a liquid asset.
  • The W.K. Kellogg Foundation Trust, as a significant shareholder, received a substantial cash sum.
  • Kellanova employees and operations are now part of a privately held entity under Acquiror 10VB8, LLC, which may lead to operational or strategic shifts.

Key Dates

DateDescription
2017-08-30Date of Power of Attorney for signing on behalf of the W.K. Kellogg Foundation.
2024-08-13Date of the Agreement and Plan of Merger entered into by Kellanova, Acquiror 10VB8, LLC, Merger Sub 10VB8, LLC, and Mars, Incorporated.
2025-12-11Date of the merger completion and the transaction date for the disposal of Kellanova common stock.
2025-12-12Date of signature for the Form 4 filing.

Keywords

Kellanova, K, Merger, Acquisition, W.K. Kellogg Foundation Trust, Beneficial Ownership, SEC Form 4, Stock Disposal, Cash Payout

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.